Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-15-065427)

Filing Details

Accession Number:: 0001209191-15-065427
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2015-08-11 21:10:09
Reporting Period:: 2015-08-07

Filing Date:: 2015-08-11
Accepted Time:: 2015-08-11 21:10:09
Original Submission Date:: 2015-08-10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1394319	Tracon Pharmaceuticals Inc.	TCON	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1590442	Partnership Limited Investment V3 Super Jafco	Otemachi First Square, West Tower 11F 1-5-1 Otemachi, Chiyoda-Ku Tokyo M0 100-0004		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-08-07	2,300	$11.83	1,815,370	No	4	S	Direct
Common Stock	Disposition	2015-08-10	6,000	$11.50	1,809,370	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The amount of securities beneficially owned following the reported transaction was previously misstated in the originally filed Form 4. This amendment corrects the amount of securities beneficially owned following the reported transaction.